Abstract
Nineteen arenaviruses have been isolated in the Old and the New World, most of them identified in South or Central America. Current evidence suggests that arenaviruses have co-evolved along with their rodent hosts over a time scale of as much as 9 million years. Among six arenaviruses so far known to cause human illness, only one, Lassa virus, is from Africa. Three other arenaviruses have been isolated in Africa: Mopeia virus from Mastomys natalensis in southern Africa (Wulff et al. 1977; Johnson et al. 1981a) and two other viruses from two different rodent species, Arvicanthus and Praomys (Gonzalez et al. 1983; Swanepoel et al. 1985) in the Central African Republic. None of them has been associated with human illness (Georges et al. 1985). Lassa fever was described as a clinical entity in the 1950s, well before the Lassa virus was identified in 1969, when it was isolated from febrile American missionaries working in northern Nigeria (Frame et al. 1970; Buckley and Casals 1970). Further expansion of the family is to be anticipated with increased efforts at surveillance, including a possible a new North American arenavirus capable of causing fatal human disease.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Anonymous (2000) Lassa fever, case imported to Germany. Wkly Epidemiol Rec 75:8–17
Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debre P, et al. (1999) Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients [see comments]. Nat Med 5:423–126
Bajani MD, Tomori O, Rollin PE, Harry TO, Bukbuk ND, Wilson L, et al. (1997) A survey for antibodies to Lassa virus among health workers in Nigeria. Trans R Soc Trop Med Hyg 91:379–381
Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, et al. (2000) Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 38:2670–2677
Biggar RJ (1986) Possible nonspecific association between malaria and HTLV-III/LAV [letter]. N Engl J Med 315:457–58
Biggar RJ, Gigase PL, Melbye M, Kestens L, Sarin PS, Bodner AJ, et al. (1985) ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet 2:520–523
Biggar RJ, Saxinger C, Sarin P, Blattner WA (1986) Non-specificity of HTLV-III reactivity in sera from rural Kenya and eastern Zaire [letter]. East Afr Med J 63:683–684
Bloch A (1978) A serological survey of Lassa fever in Liberia. Bull World Health Org 56:811–813
Bowen GS, Tomori O, Wulff H, Casals J, Noonan A, Downs WG (1975) Lassa fever in Onitsha, East Central State, Nigeria in 1974. Bull World Health Org 52:599–604
Buckley SM, Casals J (1970) Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg 19:680–691
Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, et al. (1998) Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus [see comments]. Science 282:2079–2081
Carey DE, Kemp GE, White HA, Pinneo L, Addy RF, Fom AL, et al. (1972) Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg 66:402–108
Centers for Disease Control (1988) Management of patients with suspected viral hemorrhagic fever. MMWR 37:S1–S15
Fraser DW, Campbell CC, Monath TP, Goff PA, Gregg MB (1974) Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg 23:1131–1139
Clegg JC, Lloyd G (1987) Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Lancet 2:186–188
Cooper CB, Gransden WR, Webster M, King M, O’Mahony M, Young S, et al. (1982) A case of Lassa fever: experience at St Thomas’s Hospital. Br Med J Clin Res Ed 285:1003–1005
Cummins D, Bennett D, Fisher-Hoch SP, Farrar B, McCorrnick JB (1989a) Electrocardiographic abnormalities in patients with Lassa fever. J Trop Med Hyg 92:350–355
Cummins D, Fisher-Hoch SP, Walshe KJ, Mackie I J, McCormick JB, Bennett D, et al. (1989b) A plasma inhibitor of platelet aggregation in patients with Lassa fever. Br J Haematol 72:543–548
Cummins D, McCormick JB, Bennett D, Samba JA, Farrar B, Machin SJ, et al. (1990a) Acute sensorineural deafness in Lassa fever [see comments]. JAMA 264:2093–2096
Cummins D, Molinas FC, Lerer G, Maiztegui JI, Faint R, Machin SJ (1990b) A plasma inhibitor of platelet aggregation in patients with Argentine hemorrhagic fever. Am J Trop Med Hyg 42: 470–475
Cummins D, Bennett D, Fisher-Hoch SP, Farrar B, Machin SJ, McCormick JB (1992) Lassa fever encephalopathy: clinical and laboratory findings. J Trop Med Hyg 95:197–201
Di Simone C, Buchmeier MJ (1995) Protection of mice from lethal LCMV infection by a reconstituted glycoprotein vaccine. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 1–5
Elliott LH, McCormick JB, Johnson KM (1982) Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol 16:704–708
Emond RT, Bannister B, Lloyd G, Southee TJ, Bowen ET (1982) A case of Lassa fever: clinical and virological findings. Br Med J (Clin Res Ed) 285:1001–1002
Fabiyi A, Tomori O, Pinneo P (1979) Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria. Niger Med J 9:23–25
Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D, Schnittler HJ (1996) Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol 70:2208–2214
Fisher-Hoch SP (1993) Stringent precautions are not advisable when caring for patients with viral haemorrhagic fevers. Rev Med Virol 3:7–13
Fisher-Hoch SP, McCormick JB (1987) Pathophysiology and treatment of Lassa fever. Curr Topics Microbiol Immunol 134:231–239
Fisher-Hoch SP, Price ME, Craven RB, Price FM, Forthall DN, Sasso DR, et al. (1985) Safe intensivecare management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet 2:1227–1229
Fisher-Hoch SP, Mitchell SW, Sasso DR, Lange JV, Ramsey R, McCormick JB (1987) Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J Infect Dis 155:465–474
Fisher-Hoch S, McCormick JB, Sasso D, Craven RB (1988) Hematologic dysfunction in Lassa fever. J Med Virol 26:127–135
Fisher-Hoch SP, McCormick JB, Auperin D, Brown BG, Castor M, Perez G, et al. (1989) Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci USA 86:317–321
Fisher-Hoch SP, Tomori O, Nasidi A, Perez Oronoz GI, Fakile Y, Hutwagner L, et al. (1995) Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 311:857–859
Fisher-Hoch SP, Hutwagner L, Brown B, McCormick JB (2000) Effective vaccine for lassa fever. J Virol 74:6777–6783
Frame JD, Baldwin JM Jr, Gocke DJ, Troup JM (1970) Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 19:670–676
Frame JD, Casals J, Dennis EA (1979) Lassa virus antibodies in hospital personnel in western Liberia. Trans R Soc Trop Med Hyg 73:219–224
Frame JD, Jahrling PB, Yalley Ogunro JE, Monson MH (1984) Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients. Trans R Soc Trop Med Hyg 78:656–660
Georges AJ, Gonzalez JP, Abdul Wahid S, Saluzzo JF, Meunier DM, McCormick JB (1985) Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic. Trans R Soc Trop Med Hyg 79:78–79
Gonzalez JP, McCormick JB, Saluzzo JF, Herve JP, Georges AJ, Johnson KM (1983) An arenavirus isolated from wild-caught rodents (Pramys species) in the Central African Republic. Intervirology 19:105–112
Gonzalez JP, Josse R, Johnson ED, Merlin M, Georges AJ, Abandja J, et al. (1989) Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations. Res Virol 140:319–331
Grundy DJ, Bowen ET, Lloyd G (1980) Isolated case of Lassa fever in Zaria, Northern Nigeria [letter]. Lancet 2:649–650
Helmick CG, Webb PA, Scribner CL, Krebs JW, McCormick JB (1986) No evidence for increased risk of Lassa fever infection in hospital staff. Lancet 2:1202–1205
Hirabayashi Y, Oka S, Goto H, Shimada K, Kurata T, Fisher-Hoch SP, et al. (1988) An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis 158:872–875
Hirabayashi Y, Oka S, Goto H, Shimada K, Kurata T, Fisher-Hoch SP, et al. (1989) The first imported case of Lassa fever in Japan (in Japanese). Nippon Rinsho 47:71–75
Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, et al. (1990) Lassa fever in the United States. Investigation of a case and new guidelines for management [see comments]. N Engl J Med 323:1120–1123
Johnson KM, Webb PA, Kuns ML, Valverde L (1967) On the mode of transmission of Bolivian hemorrhagic fever. Jpn J Med Sci Biol 20:153–159
Johnson KM, Taylor P, Elliott LH, Tomori O (1981a) Recovery of a Lassa-related arenavirus in Zimbabwe. Am J Trop Med Hyg 30:1291–1293
Johnson KM, Elliott LH, Heymann DL (1981b) Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys. J Clin Microbiol 14:527–529
Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ (1987) Clinical virology of Lassa fever in hospitalized patients. J Infect Dis 155:456–464
Keenlyside RA, McCormick JB, Webb PA, Smith E, Elliott L, Johnson KM (1983) Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone. Am J Trop Med Hyg 32:829–837
Knobloch J, McCormick JB, Webb PA, Dietrich M, Schumacher HH, Dennis E (1980) Clinical observations in 42 patients with Lassa fever. Tropenmed Parasitol 31:389–398
Lukashevich IS (1992) Generation of reassortants between African arenaviruses. Virology 188:600–605
Lukashevich IS, Vasiuchkov AD, Stel’makh TA, Scheslenok EP, Shabanov AG (1991) The isolation and characteristics of reassortants between the Lassa and Mopeia arenaviruses. Vopr Virusol 36:146–150
Lukashevich IS, Maryankova R, Vladyko AS, Nashkevich N, Koleda S, Djavani M, et al. (1999) Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J Med Virol 59:552–560
Marta RF, Montero VS, Hack CE, Sturk A, Maiztegui JI, Molinas FC (1999) Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever. Am J Trop Med Hyg 60:85–89
Martini GA, Schmidt HA (1968) Spermatogene Ubertragung des ‘Virus Marburg’. (Erreger der ‘Marburger Affenkrankheit’). Klin Wochenschr 46:398–100
McCormick JB (1986) Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med Microbiol Immunol Berl 175:153–155
McCormick JB (1987) Epidemiology and control of Lassa fever. Curr Topics Microbiol Immunol 134:69–78
McCormick JB (1988) Lassa fever: epidemiology, therapy and vaccine development. Kansenshogaku. Zasshi 62 [Suppl]:353–366
McCormick JB (1990) Arenaviruses. In: Fields BN, Knipe DM (eds) Fields virology, 2nd edn. Raven Press, New York, pp 1245–1267
McCormick JB, Walker DH, King IJ, Webb PA, Elliott LH, Whitfield SG, et al. (1986) Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am J Trop Med Hyg 35:401–107
McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES (1987a) A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 155:437–444
McCormick JB, King I J, Webb PA, Johnson KM, O’Sullivan R, Smith ES, et al. (1987b) A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155:445–455
McCormick JB, Mitchell SW, Kiley MP, Ruo S, Fisher-Hoch SP (1992) Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys. J Med Virol 37:1–7
Mertens PE, Patton R, Baum J J, Monath TP (1973) Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg 22:780–784
Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, Pinneo L, et al. (1973) A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg 22:773–779
Monath TP, Maher M, Casals J, Kissling RE, Cacciapuoti A (1974) Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg 23:1140–1149
Monson MH, Cole AK, Frame JD, Serwint JR, Alexander S, Jahrling PB (1987) Pediatric Lassa fever: a review of 33 Liberian cases. Am J Trop Med Hyg 36:408–115
Morrison HG, Bauer SP, Lange JV, Esposito J J, McCormick JB, Auperin DD (1989) Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology 171:179–188
Morrison HG, Goldsmith CS, Regnery HL, Auperin DD (1991) Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus. Virus Res 18:231–241
Price ME, Fisher-Hoch SP, Craven RB, McCormick JB (1988) A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ 297:584–587
Riviere Y, Ahmed R, Southern PJ, Buchmeier MJ, Oldstone MB (1985) Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment. J Virol 55:704–709
Robbins CB, Krebs JW Jr, Johnson KM (1983) Mastomys (Rodentia: Muridae) species distinguished by hemoglobin pattern differences. Am J Trop Med Hyg 32:624–630
Roberts PJ, Cummins D, Bainton AL, Walshe KJ, Fisher-Hoch SP, McCormick JB, Gribben JG, Machin SJ, Linch DC (1989) Plasma from patients with severe Lassa fever profoundly modulates f-met-leu-phe induced superoxide generation in neutrophils. Br J Haematol 73:152–157
Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, et al. (1999) Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179 [Suppl 1]:S28–S35
Saluzzo JF, Adam F, McCormick JB, Digoutte JP (1988) Lassa fever virus in Senegal [letter]. J Infect Dis 157:605
Schnittler HJ, Mahner F, Drenckhahn D, Klenk HD, Feldmann H (1993) Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest 91:1301–1309
Siegert R, Shu HL, Slenczka W (1968) Demonstration of the ‘Marburg virus’ in the patient (in German). Nachweis des “Marburg-Virus” beim Patienten. Dtsch Med Wochenschr 93:616–619
Swanepoel R, Leman PA, Shepherd AJ, Shepherd SP, Kiley MP, McCormick JB (1985) Identification of Ippy as a Lassa-fever-related virus [letter]. Lancet 1:639
Ter Meulen J, Lukashevich I, Sidibe K, Inapogui A, Marx M, Dorlemann A, et al. (1996) Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg 55:661–666
Ter Meulen J, Badusche M, Kuhnt K, Doetze A, Satoguina J, Marti T, et al. (2000) Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the lassa virus nucleoprotein. J Virol 74:2186–2192
Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB (1988) Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg 38:407–410
Trappier SG, Conaty AL, Farrar BB, Auperin DD, McCormick JB, Fisher-Hoch SP (1993) Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am J Trop Med Hyg 49:214–221
Troup JM, White HA, Fom AL, Carey DE (1970) An outbreak of Lassa fever on the Jos plateau, Nigeria, in January-February 1970. A preliminary report. Am J Trop Med Hyg 19:695–696
Walker DH, Johnson KM, Lange JV, Gardner JJ, Kiley MP, McCormick JB (1982) Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. J Infect Dis 146:360–368
Webb PA, McCormick JB, King I J, Bosman I, Johnson KM, Elliott LH, et al. (1986) Lassa fever in children in Sierra Leone, West Africa. Trans R Soc Trop Med Hyg 80:577–582
White HA (1972) Lassa fever. A study of 23 hospital cases. Trans R Soc Trop Med Hyg 66:390–401
Winn WC Jr, Walker DH (1975) The pathology of human Lassa fever. Bull World Health Org 52: 535–545
Wright KE, Salvato MS, Buchmeier MJ (1989) Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression. Virology 171:417–426
Wright KE, Spiro RC, Burns JW, Buchmeier MJ (1990) Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus. Virology 177:175–183
Wulf TH, Fabiyi A, Monath TP (1975) Recent isolations of Lassa virus from Nigerian rodents. Bull World Health Org 52:609–613
Wulff H, Mcintosh BM, Hamner DB, Johnson KM (1977) Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in south-east Africa. Bull World Health Org 55:441–144
Yalley-Ogunro JE, Frame JD, Hanson AP (1984) Endemic Lassa fever in Liberia. VI. Village serological surveys for evidence of Lassa virus activity in Lofa County, Liberia. Trans R Soc Trop Med Hyg 78:764–770
Yang Z, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ (2000) Identification of the ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 6:886–889
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
McCormick, J.B., Fisher-Hoch, S.P. (2002). Lassa Fever. In: Oldstone, M.B.A. (eds) Arenaviruses I. Current Topics in Microbiology and Immunology, vol 262. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56029-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-56029-3_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42244-0
Online ISBN: 978-3-642-56029-3
eBook Packages: Springer Book Archive